Drug intelligence / Profile preview

13C-labeled lactate

Development stage
Preclinical
Lead developer
Karolinska University Hospital
Modality
Small Molecules
Administration
Intravenous
01

Overview

13C-labeled lactate is a stable isotope tracer compound consisting of lactate labeled with the non-radioactive carbon-13 isotope. Developed and studied by researchers at Karolinska University Hospital and Karolinska Institutet, it is utilized as an investigational metabolic tracer rather than a therapeutic agent. The compound is administered intravenously (typically as a single bolus) to characterize lactate kinetics, specifically the rate of appearance and metabolic clearance in the blood of critically ill ICU patients with organ failure. By tracking the isotope, researchers can perform non-compartmental modeling to understand altered lactate metabolism during critical illness without exposing patients to ionizing radiation.

Other names
13C-lactate[13C]lactatecarbon-13 labeled lactatecarbon13 labeled lactatecarbon 13 labeled lactate13C-labeled sodium lactateisotopically-labeled lactate
02

Targets

MCT4 (Monocarboxylate transporter 4)LDH (L-lactate dehydrogenase A chain)

Beyond the preview

Go deeper on 13C-labeled lactate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 13C-labeled lactate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call